Testing a new treatment for pancreatic cysts
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a new method using an endoscope (a thin tube with a camera) to deliver a chemotherapy drug directly into a pancreatic cyst called IPMN. The goal is to see if this approach is safe and can prevent the cyst from growing or turning into cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a branch duct IPMN (a type of pancreatic cyst) that is at least 3 cm or has been growing.
- You are healthy enough to have an endoscopy under deep sedation or general anesthesia.
- You do not have known or suspected pancreatic cancer, or certain high-risk features like a very large main duct or jaundice.
- You are not pregnant, breastfeeding, and have no serious bleeding or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new procedure using an ultrasound camera passed through your mouth to inject medicine directly into pancreatic cysts. It may help shrink cysts in people who cannot have surgery.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
This trial tests a minimally invasive endoscopic procedure that uses heat to treat certain pancreatic cysts (fluid-filled sacs) and small neuroendocrine tumors (hormone-producing growths). It may be an option if surgery isn't possible or if you prefer to avoid it.
This study tests whether an endoscopy-based “radiofrequency ablation” (controlled heating) can manage certain pancreatic cysts that look high-risk. It’s designed for people who are not good candidates for surgery, aiming to shrink or control the cyst safely.
This trial tests a new drug called IBI343 combined with standard chemotherapy for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
This trial tests a new drug called mitazalimab injected directly into the tumor, combined with a special electrical procedure that kills cancer cells. It is for people whose pancreatic cancer has not spread but cannot be removed by surgery.
Hear when a new Intraductal Papillary Mucinous Neoplasm of Pancreas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.